UnitedHealth Group (NYSE:UNH) had its target price lifted by Oppenheimer from $295.00 to $300.00 in a report released on Wednesday morning, The Fly reports. Oppenheimer currently has an outperform rating on the healthcare conglomerate’s stock. Oppenheimer also issued estimates for UnitedHealth Group’s Q1 2019 earnings at $3.45 EPS, Q3 2019 earnings at $3.84 EPS, Q4 2019 earnings at $3.73 EPS and FY2019 earnings at $14.57 EPS.
Several other analysts also recently commented on the stock. Piper Jaffray Companies raised their price objective on shares of UnitedHealth Group to $312.00 and gave the company an overweight rating in a research report on Wednesday. BMO Capital Markets set a $310.00 target price on shares of UnitedHealth Group and gave the company a buy rating in a research note on Tuesday, November 27th. Zacks Investment Research raised shares of UnitedHealth Group from a hold rating to a buy rating and set a $292.00 target price for the company in a research note on Monday, November 26th. Cantor Fitzgerald reaffirmed a buy rating and set a $310.00 target price on shares of UnitedHealth Group in a research note on Wednesday, November 21st. Finally, Argus raised their target price on shares of UnitedHealth Group to $285.00 and gave the company a buy rating in a research note on Thursday, October 18th. Two equities research analysts have rated the stock with a hold rating and twenty-one have assigned a buy rating to the company’s stock. The stock currently has a consensus rating of Buy and an average price target of $292.48.
Shares of UNH stock opened at $281.36 on Wednesday. The firm has a market cap of $271.82 billion, a PE ratio of 27.94, a PEG ratio of 1.63 and a beta of 0.78. UnitedHealth Group has a one year low of $208.48 and a one year high of $285.45. The company has a debt-to-equity ratio of 0.61, a quick ratio of 0.69 and a current ratio of 0.69.
The firm also recently disclosed a quarterly dividend, which will be paid on Thursday, December 13th. Shareholders of record on Monday, December 3rd will be paid a $0.90 dividend. The ex-dividend date is Friday, November 30th. This represents a $3.60 dividend on an annualized basis and a dividend yield of 1.28%. UnitedHealth Group’s payout ratio is currently 35.75%.
In other UnitedHealth Group news, CEO Steven H. Nelson sold 26,033 shares of UnitedHealth Group stock in a transaction on Friday, September 7th. The shares were sold at an average price of $270.65, for a total value of $7,045,831.45. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available through this hyperlink. Also, Director Richard T. Burke sold 6,090 shares of UnitedHealth Group stock in a transaction on Wednesday, November 28th. The stock was sold at an average price of $281.72, for a total transaction of $1,715,674.80. Following the completion of the transaction, the director now directly owns 1,711,584 shares of the company’s stock, valued at $482,187,444.48. The disclosure for this sale can be found here. Insiders sold a total of 60,428 shares of company stock valued at $16,232,134 over the last three months. Corporate insiders own 0.87% of the company’s stock.
Large investors have recently modified their holdings of the business. Cornerstone Wealth Management LLC boosted its stake in shares of UnitedHealth Group by 24,755.2% during the 2nd quarter. Cornerstone Wealth Management LLC now owns 245,569 shares of the healthcare conglomerate’s stock worth $992,000 after purchasing an additional 244,581 shares during the period. Middleton & Co Inc MA boosted its stake in shares of UnitedHealth Group by 6.8% during the 2nd quarter. Middleton & Co Inc MA now owns 26,973 shares of the healthcare conglomerate’s stock worth $6,618,000 after purchasing an additional 1,720 shares during the period. ACG Wealth purchased a new position in shares of UnitedHealth Group during the 2nd quarter worth about $5,692,000. Sheets Smith Wealth Management purchased a new position in shares of UnitedHealth Group during the 2nd quarter worth about $2,295,000. Finally, Granite Investment Advisors LLC boosted its stake in shares of UnitedHealth Group by 1.4% during the 2nd quarter. Granite Investment Advisors LLC now owns 34,225 shares of the healthcare conglomerate’s stock worth $8,397,000 after purchasing an additional 476 shares during the period. 85.45% of the stock is owned by institutional investors and hedge funds.
About UnitedHealth Group
UnitedHealth Group Incorporated operates as a diversified health care company in the United States. It operates through four segments: UnitedHealthcare, OptumHealth, OptumInsight, and OptumRx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older, addressing their needs for preventive and acute health care services, as well as services dealing with chronic disease and other specialized issues for older individuals; and Medicaid plans, Children's Health Insurance Program, and health care programs; and health and dental benefits.
Featured Article: How to Calculate Compound Annual Growth Rate (CAGR)
Receive News & Ratings for UnitedHealth Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for UnitedHealth Group and related companies with MarketBeat.com's FREE daily email newsletter.